Background. Difficulties in coping with cancer, and the accompanying anxious and
depressive symptoms, have been shown to affect the mood and the quality of life in breast …

Background: 5-HTTLPR genetic polymorphism of serotonin transporter (SERT) and stressful
life events facilitate depression. The aim of this investigation was therefore to determine the …

Introduction: Post-traumatic Symptoms (PTSS) and Post-traumatic Stress Disorder (PTSD)
have been reported to affect a quite significant proportion of cancer patients. No study has …

BACKGROUND: Mixed evidence in the general population and medically ill patients has
suggested that homozygous carriers of the short allele (s/s) of the serotonin transporter gene …

Purpose This study tested a theory linking a marker of low serotonergic function to both
depression and impulsivity in a sample of advanced breast cancer patients, among whom …

Background Depression following the diagnosis of breast cancer has been well
documented, and occurs in as many as 40% of women. The serotonin transporter gene …

Depression is difficult to detect in cancer patients, though its determination offers an
opportunity to relieve patients' suffering in palliative care. Selective serotonin reuptake …

Background Nearly 50% of women with breast cancer show depressive symptoms after
diagnosis and treatment. The purpose of this study was to clarify how psychosocial factors …

Background Depressive symptoms are highly prevalent in breast cancer patients. These
symptoms can contribute to lower treatment adherence, increased healthcare charges, and …

Objective Polymorphisms of serotonin transporter (5-HTT) and brain-derived neurotrophic
factor (BDNF) genes have been investigated as candidate genes for depression occurring in …